Publications

2013

13/01 Couturier-Maillard A, Secher T, Rehman A, Normand S, De Arcangelis A, Haesler R, Huot L, Grandjean T, Bressenot A, Delanoye-Crespin A, Gaillot O, Schreiber S, Lemoine Y, Ryffel B, Hot D, Nùñez G, Chen G, Rosenstiel P, Chamaillard M. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Invest., 123(2), 700–711.

13/02 Chamaillard M, Chevaux JB, Peyrin-Biroulet L. Looking beyond histological healing in ulcerative colitis: towards the establishment of a molecular signature for quiescent but progressive disease. Gut., 62(7), 959-60.

13/03 Ubelmann F, Chamaillard M, El-Marjou F, Simon A, Netter J, Vignjevic D, Nichols BL, Quezada-Calvillo R, Grandjean T, Louvard D, Revenu C and Robine S. Enterocyte loss of Q:1; 2 polarity and gut wound healing rely upon the F-actin–severing function of villin. Proc Natl Acad Sci U S A., 110(15), E1380-9.

13/04 Sedhom MA, Pichery M, Murdoch JR, Foligné B, Ortega N, Normand S, Mertz K, Sanmugalingam D, Brault L, Grandjean T, Lefrancais E, Fallon PG, Quesniaux V, Peyrin-Biroulet L, Cathomas G, Junt T, Chamaillard M, Girard JP, Ryffel B. Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice. Gut., in press, DOI: 10.1136/gutjnl-2011-301785.

13/05 Wuensch T, Schulz S, Ullrich S, Lill N, Stelzl T, Rubio-Aliaga I, Loh G, Chamaillard M, Haller D, Daniel H. The peptide transporter PEPT1 is expressed in distal colon in rodents and humans and contributes to water absorption. Am. J. Physiol. Gastrointest. Liver. Physiol., 305(1):G66-73.

13/06 Chauvin C, Peyrin-Biroulet, L, Chamaillard M, Poulin, LF. Phagocytes migration in response to an emergency call from the microbiota. Gastroenterology., 145(5):1150-1

13/07 Secher T, Normand S, Chamaillard M. NOD2 prevents emergence of disease-predisposing microbiota. Gut Microbes, 4(4):353-6.

13/08 Normand S, Secher T, Chamaillard M. La dysbiose, nouvelle entité en médecine ? Médecine/Sciences, 29(6-7):586-9.

13/09 Renaud N, Lecci L, Courcol RJ, Simonet M, Gaillot O. CHROMagar Yersinia: a new chromogenic agar for the screening of potentially pathogenic Yersinia enterocolitica in stools. J Clin Microbiol., 51(4), 1184-7.

13/10 Le Quellec S, Gaillot O, Chotel F, Freydière AM, Laurent F, Vandenesch F, Doléans-Jordheim A. Septic Arthritis Caused by Noncapsulated Haemophilus influenzae. J. Clin. Microbiol., 51(6), 1970-2.

13/11 Gaillot O, Lemenand O, Marceau M, Simonet M. Proposed reclassification of Pasteurella lymphangitidis Sneath & Stevens 1990 as Yersinia pseudotuberculosis. International Journal of Systematic and Evolutionary Microbiology. 2013 (in press).

2012

12/01 van Ampting MT, Loonen LM, Schonewille, AJ., Konings I, Vink C, Iovanna J, Chamaillard M, Dekker J, van der Meer R, Wells JM, Bovee-Oudenhoven IM. Intestinally secreted C-type lectin Reg3b attenuates salmonellosis but not listeriosis in mice. Infect. Immun., 80(3), 1115-20.

2011

11/01 Normand S, Delanoye-Crespin A, Bressenot A, Huot L, Grandjean T, Peyrin-Biroulet L, Lemoine Y, Hot D, Chamaillard M. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc. Natl. Acad. Sci. U S A., 108(23), 9601-6.

11/02 Anderson CA, Boucher G, Lees CW, Franke A, D’Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, Lagacé C, Scott R, Amininejad L, Bumpstead S, Baidoo L, Baldassano RN, Barclay M, Bayless TM, Brand S, Büning C, Colombel JF, Denson LA, De Vos M, Dubinsky M, Edwards C, Ellinghaus D, Fehrmann RS, Floyd JA, Florin T, Franchimont D, Franke L, Georges M, Glas J, Glazer NL, Guthery SL, Haritunians T, Hayward NK, Hugot JP, Jobin G, Laukens D, Lawrance I, Lémann M, Levine A, Libioulle C, Louis E, McGovern DP, Milla M, Montgomery GW, Morley KI, Mowat C, Ng A, Newman W, Ophoff RA, Papi L, Palmieri O, Peyrin-Biroulet L, Panés J, Phillips A, Prescott NJ, Proctor DD, Roberts R, Russell R, Rutgeerts P, Sanderson J, Sans M, Schumm P, Seibold F, Sharma Y, Simms LA, Seielstad M, Steinhart AH, Targan SR, van den Berg LH, Vatn M, Verspaget H, Walters T, Wijmenga C, Wilson DC, Westra HJ, Xavier RJ, Zhao ZZ, Ponsioen CY, Andersen V, Torkvist L, Gazouli M, Anagnou NP, Karlsen TH, Kupcinskas L, Sventoraityte J, Mansfield JC, Kugathasan S, Silverberg MS, Halfvarson J, Rotter JI, Mathew CG, Griffiths AM, Gearry R, Ahmad T, Brant SR, Chamaillard M, Satsangi J, Cho JH, Schreiber S, Daly MJ, Barrett JC, Parkes M, Annese V, Hakonarson H, Radford-Smith G, Duerr RH, Vermeire S, Weersma RK, Rioux JD. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet., 43(3), 246-52.

11/03 Chamaillard M, Dessein R. Defensins couple dysbiosis to primary immunodeficiency in Crohn’s disease. World. J. Gastroenterol., 17(5):567-71.

11/04 Gaillot O, Blondiaux N, Loïez C, Wallet F, Lemaître N, Herwegh S, Courcol R J. Cost-effectiveness of switch to matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine bacterial identification. J. Clin. Microbiol., 49, 4412.

11/05 Naas T, Cuzon G, Gaillot O, Courcol R, Nordmann P. When carbapenem-hydrolyzing beta-lactamase Kpc meets Escherichia coli ST131 in France. Antimicrob. Agents Chemother., 55(10), 4933-4.

2010

10/01 Peyrin-Biroulet L, Beisner J, Wang G, Nuding S, Oommen ST, Kelly D, Parmentier-Decrucq E, Dessein R, Merour E, Chavatte P, Grandjean T, Bressenot A, Desreumaux P, Colombel JF, Desvergne B, Stange EF, Wehkamp J, Chamaillard M. Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc. Natl. Acad. Sci. U S A., 107(19), 8772-7.

10/02 Rehaume LM, Jouault T, Chamaillard M. Lessons from the inflammasome: a molecular sentry linking Candida and Crohn’s disease. Trends Immunol., 31(5), 171-5.

10/03 Secher T, Gaillot O, Ryffel B, Chamaillard M. Remote control of intestinal tumorigenesis by innate immunity. Cancer Res., 70(5), 1749-52.

10/04 André MF, Aumaître O, Grateau G, Chamaillard M, Costedoat-Chalumeau N, Cardoso MC, Henry-Berger J, Ramakrishna BS, Delpech M, Piette JC, Creveaux I. Longest Form of CCTG Microsatellite Repeat in the Promoter of the CD2BP1/PSTPIP1 Gene Is Associated with Aseptic Abscesses and with Crohn Disease in French Patients. Dig. Dis. Sci., 55(6), 1681-8.

10/05 Joossens M, Van Steen K, Branche J, Sendid B, Rutgeerts P, Vasseur F, Poulain D, Broly F, Colombel JF, Vermeire S, Chamaillard M. Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn’s disease. Inflamm. Bowel Dis., 16(1), 58-67.

10/06 Chabelskaya S, Gaillot O, Felden B. A Staphylococcus aureus small RNA is required for bacterial virulence and regulates the expression of an immune-evasion molecule. PLoS Pathogens, 6, e1000927.

10/07 Blondiaux N, Gaillot O, Courcol RJ. [MALDI-TOF mass spectrometry to identify clinical bacterial isolates: evaluation in a teaching hospital in Lille]. Pathol Biol (Paris)., 58(1), 55-7.

2009

09/01 Dessein R, Gironella M, Vignal C, Peyrin-Biroulet L, Sokol H, Secher T, Lacas-Gervais S, Gratadoux JJ, Lafont F, Dagorn JC, Ryffel B, Akira S, Langella P, Nùñez G, Sirard JC, Iovanna J, Simonet M, Chamaillard M. TLR2 is critical for induction of REG3beta expression and intestinal clearance of Yersinia pseudotuberculosis. Gut., 58(6), 771-6.

09/02 Koslowski M, Wang G, Chamaillard M, Kübler I, Schaeffeler E, Reinisch W, Teml A, Peyrin-Biroulet L, Winter S, Herrlinger KR, Rutgeerts P, Vermeire S, Cooney R, Fellermann K, Jewell D, Bevins CL, Schwab M, Stange EF, Wehkamp J. Genetic variants of Wnt transcription factor Tcf-4 (Tcf7L2) putative promoter region are associated with small intestinal Crohn´s disease. PLoS One., 4(2), e4496.

09/03 Standaert-Vitse A, Sendid B, Joossens M, François N, Vandewalle-El Khoury P, Branche J, Van Kruiningen H, Jouault T, Rutgeerts P, Gower-Rousseau C, Libersa C, Neut C, Broly F, Chamaillard M, Vermeire S, Poulain D, Colombel JF. Candida albicans colonization and ASCA in familial Crohn’s disease. Am J Gastroenterol., 104(7), 1745-53.

09/04 Dessein R, Chamaillard M, Danese S. Innate immunity in Crohn’s Disease: the reverse side of the medal. J. Clin. Gastroenterol., 42 Suppl 3 Pt 1, S144-7.

09/05 Dessein R, Rosenstiel P, Chamaillard M. Debugging the intestinal microbiota in IBD. Gastroenterol Clin Biol. 33 Suppl 3:S131-6. WOS:000269965500003.

09/06 Dessein R, Peyrin-Biroulet L, Chamaillard M. Intestinal microbiota gives a nod to the hygiene hypothesis in type 1 diabetes. Gastroenterology., 137(1), 381-3.

09/07 Gaillard T, Gaillard C, Martinaud C, Souraud JB, Lamblin G, Gaillot O, Brisou P. Abdominal granuloma in a young healthy man after infection with Pasteurella multocida. Am. J. Gastroenterol., 104(9), 2357-8.

09/08 Marois C, Fablet C, Gaillot O, Morvan H, Madec F, Kobisch M. Molecular diversity of porcine and human isolates of Pasteurella multocida. J. Appl. Microbiol. 2009 Dec 1;107(6):1830-6.

2008

08/01 Vandewalle-El Khoury P, Colombel JF, Joossens S, Standaert-Vitse A, Collot M, Halfvarson J, Ayadi A, Landers CJ, Vermeire S, Rutgeerts P, Targan SR, Chamaillard M, Mallet JM, Sendid B, Poulain D. Detection of antisynthetic mannoside antibodies (A Sigma MA) reveals heterogeneity in the ASCA response of Crohn’s disease patients and contributes to differential diagnosis, stratification, and prediction. Am. J. Gastroenterol., 103(4), 949-957.

08/02 Body-Malapel M, Dharancy S, Berrebi D, Louvet A, Hugot JP, Philpott DJ, Giovannini M, Chareyre F, Pages G, Gantier E, Girardin SE, Garcia I, Hudault S, Conti F, Sansonetti PJ, Chamaillard M, Desreumaux P, Dubuquoy L, Mathurin P. NOD2: a potential target for regulating liver injury. Lab Invest., 88(3), 318-327.

08/03 Lobel B, Valot A, Cattoir V, Lemenand O, Gaillot O. [Comparison of antimicrobial susceptibility of 1,217 Escherichia coli isolates from women with hospital and community-acquired urinary tract infections]. Presse Med., 37(5 Pt 1), 746-50.

Cette note est également disponible en: Anglais